Vasopressin
CGMP Deviations
Yes — there is an active recall. 6 ongoing FDA recalls mention Vasopressin (12 total). Check the affected lots below.
Most common reason: Wrong potency / content (6 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Vasopressin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
CGMP Deviations
CGMP Deviations
Subpotent Drug
Subpotent product in addition to having out-of-specification results for impurities.
Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
Subpotent Drug
Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.